Literature DB >> 32354610

Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.

Ann-Christin Woerl1, Markus Eckstein2, Josephine Geiger1, Daniel C Wagner3, Tamas Daher3, Philipp Stenzel3, Aurélie Fernandez3, Arndt Hartmann2, Michael Wand4, Wilfried Roth3, Sebastian Foersch5.   

Abstract

BACKGROUND: Muscle-invasive bladder cancer (MIBC) is the second most common genitourinary malignancy, and is associated with high morbidity and mortality. Recently, molecular subtypes of MIBC have been identified, which have important clinical implications.
OBJECTIVE: In the current study, we tried to predict the molecular subtype of MIBC samples from conventional histomorphology alone using deep learning. DESIGN, SETTING, AND PARTICIPANTS: Two cohorts of patients with MIBC were used: (1) The Cancer Genome Atlas Urothelial Bladder Carcinoma dataset including 407 patients and (2) our own cohort including 16 patients with treatment-naïve, primary resected MIBC. This resulted in a total of 423 digital whole slide images of tumor tissue to train, validate, and test the deep learning algorithm to predict the molecular subtype. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Various accuracy measurements including the area under the receiver operating characteristic curves were used to evaluate the deep learning model. A sliding window approach to visualize classification was used. Class activation maps were used to identify image features that are most relevant to call a specific class. RESULTS AND LIMITATIONS: The deep learning model showed great performance in the prediction of the molecular subtype of MIBC patients from hematoxylin and eosin (HE) slides alone-similar to or better than pathology experts. Using different visualization techniques, we identified new histopathological features that were most relevant to our model.
CONCLUSIONS: Deep learning can be used to predict important molecular features in MIBC patients from HE slides alone, potentially improving the clinical management of this disease significantly. PATIENT
SUMMARY: In patients with bladder cancer, a computer program found changes in the appearance of tumor tissue under the microscope and used these to predict genetic alterations. This could potentially benefit patients.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deep learning; Histopathology; Molecular subtype; Muscle-invasive bladder cancer

Mesh:

Year:  2020        PMID: 32354610     DOI: 10.1016/j.eururo.2020.04.023

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  18 in total

Review 1.  Artificial Intelligence in Pathology.

Authors:  Sebastian Försch; Frederick Klauschen; Peter Hufnagl; Wilfried Roth
Journal:  Dtsch Arztebl Int       Date:  2021-03-26       Impact factor: 5.594

Review 2.  Advances in Digital Pathology: From Artificial Intelligence to Label-Free Imaging.

Authors:  Frederik Großerueschkamp; Hendrik Jütte; Klaus Gerwert; Andrea Tannapfel
Journal:  Visc Med       Date:  2021-08-24

3.  Increasing a microscope's effective field of view via overlapped imaging and machine learning.

Authors:  Xing Yao; Vinayak Pathak; Haoran Xi; Amey Chaware; Colin Cooke; Kanghyun Kim; Shiqi Xu; Yuting Li; Timothy Dunn; Pavan Chandra Konda; Kevin C Zhou; Roarke Horstmeyer
Journal:  Opt Express       Date:  2022-01-17       Impact factor: 3.894

4.  Swarm learning for decentralized artificial intelligence in cancer histopathology.

Authors:  Oliver Lester Saldanha; Philip Quirke; Nicholas P West; Jacqueline A James; Maurice B Loughrey; Heike I Grabsch; Manuel Salto-Tellez; Elizabeth Alwers; Didem Cifci; Narmin Ghaffari Laleh; Tobias Seibel; Richard Gray; Gordon G A Hutchins; Hermann Brenner; Marko van Treeck; Tanwei Yuan; Titus J Brinker; Jenny Chang-Claude; Firas Khader; Andreas Schuppert; Tom Luedde; Christian Trautwein; Hannah Sophie Muti; Sebastian Foersch; Michael Hoffmeister; Daniel Truhn; Jakob Nikolas Kather
Journal:  Nat Med       Date:  2022-04-25       Impact factor: 87.241

5.  Deep learning in MIBC.

Authors:  Tim Thomas
Journal:  Nat Rev Urol       Date:  2020-08       Impact factor: 14.432

6.  Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.

Authors:  Jiao Hu; Anze Yu; Belaydi Othmane; Dongxu Qiu; Huihuang Li; Chao Li; Peihua Liu; Wenbiao Ren; Minfeng Chen; Guanghui Gong; Xi Guo; Huihui Zhang; Jinbo Chen; Xiongbing Zu
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

7.  Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis.

Authors:  Yao Kang; Xiaojun Zhu; Xijun Wang; Shiyao Liao; Mengran Jin; Li Zhang; Xiangyang Wu; Tingxiao Zhao; Jun Zhang; Jun Lv; Danjie Zhu
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

8.  Multimodal Deep Learning for Prognosis Prediction in Renal Cancer.

Authors:  Stefan Schulz; Ann-Christin Woerl; Florian Jungmann; Christina Glasner; Philipp Stenzel; Stephanie Strobl; Aurélie Fernandez; Daniel-Christoph Wagner; Axel Haferkamp; Peter Mildenberger; Wilfried Roth; Sebastian Foersch
Journal:  Front Oncol       Date:  2021-11-24       Impact factor: 6.244

9.  5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer.

Authors:  Jiao Hu; Belaydi Othmane; Anze Yu; Huihuang Li; Zhiyong Cai; Xu Chen; Wenbiao Ren; Jinbo Chen; Xiongbing Zu
Journal:  BMC Med       Date:  2021-11-26       Impact factor: 8.775

Review 10.  Deep learning in cancer diagnosis, prognosis and treatment selection.

Authors:  Khoa A Tran; Olga Kondrashova; Andrew Bradley; Elizabeth D Williams; John V Pearson; Nicola Waddell
Journal:  Genome Med       Date:  2021-09-27       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.